ULBI in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with ULBI today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Most of Ultralife Corporation’s revenue comes from batteries and related power products sold to equipment manufacturers, other commercial customers and defense buyers. It makes rechargeable and non-rechargeable batteries and charging systems for equipment such as medical devices, military radios and oilfield instruments. Commercial customers supply most of its revenue. A smaller business builds military communications equipment and integrates it into portable, vehicle-mounted and fixed-site systems.
Customers pay for products and services, chiefly through purchase orders placed directly or through distributors. Defense contractor L3Harris Technologies supplies a substantial share of revenue, making its ordering decisions particularly important. Long-term contracts do not guarantee purchase volumes or when orders will arrive, and military orders can depend on government budget timing.
Government sales are subject to procurement rules. Governments can terminate contracts, and noncompliance can lead to payment suspension or exclusion from government contracting.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Ultralife's results hinge on commercial and defense demand for specialty batteries and orders from L3Harris Technologies, its largest customer at 27% of 2025 revenue.
EnerSys competes with Ultralife to sell specialty batteries, chargers and power equipment to defense, portable-power, medical and security customers. Its Specialty business is the part to watch for demand in defense and medical applications that also matter to Ultralife.
Energizer competes with Ultralife in non-rechargeable and specialty batteries for consumer devices such as smoke alarms, but Ultralife focuses much more on engineered products for commercial and defense customers. Energizer's household and specialty battery sales, largely through retailers, are the relevant comparison—not its auto care or portable lighting businesses.
Ultralife Corporation earningsThis company
Ultralife’s report will show whether battery sales are translating into stronger segment contribution and whether delayed Communications Systems orders are shipping.
Read Battery & Energy Products segment contribution alongside its gross margin, then check whether Communications Systems revenue recovers. Segment contribution is gross profit less direct selling, general and administrative expenses and research and development. Higher contribution with a steady margin would show battery sales are covering direct costs more effectively; a recovery in Communications Systems revenue would indicate delayed orders are turning into shipments. If sales rise but contribution or margin weakens, or Communications Systems stays soft, growth has not yet built a firmer earnings base.
EnerSys, Inc. earningsENS
EnerSys’s Specialty report will show how defense and medical customers are buying specialty batteries and power equipment in markets where it competes with Ultralife.
Focus on EnerSys’s Specialty sales and what it says about defense and medical demand. Stronger demand would indicate that these shared markets are taking in specialty batteries and power equipment, supporting the market Ultralife competes in; weaker demand would suggest a more difficult market for Ultralife’s related products. EnerSys’s results describe the market, not Ultralife’s own orders or results.